Searched for
PHILADELPHIA CHROMOSOME POSITIVE
Lupin rolls out generic oncology drug in US marketDrug firm Lupin has launched a generic cancer treatment medication in the US. The company introduced Dasatinib Tablets in various strengths...- Alembic Pharmaceuticals gets USFDA nod for generic blood cancer treatment drugAlembic Pharmaceuticals has secured final approval from the USFDA for its generic Dasatinib tablets. These tablets are used to treat certai...
- Zydus Lifesciences shares zoom 7% after USFDA nod for Dasatinib tabletsZydus Lifesciences share price: Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multi...
- Biocon shares up 3% after US FDA nod for key cancer drugsBiocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, en...
- Cipla shares in focus after U.S. FDA nod for Leukemia drugCipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib...
- Stocks in news: Biocon, Nykaa, Britannia, Tata Consumer, NestleBiocon has tentative approval from USFDA for Dasatinib Tablets, which are used to treat Philadelphia Chromosome Positive Chronic Myeloid Le...
- Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib CapsulesShares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...
- Alembic gets USFDA nod for cancer treatment drugDasatinib Tablet is indicated for the treatment of newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) i...
Load More